John R. Pinion II
2019
In 2019, John R. Pinion II earned a total compensation of $3.4M as Chief Quality Officer and Executive Vice President, Translational Sciences at Ultragenyx Pharmaceutical, a 111% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $205,490 |
|---|---|
| Option Awards | $923,578 |
| Salary | $447,690 |
| Stock Awards | $1,756,300 |
| Other | $37,472 |
| Total | $3,370,530 |
Pinion received $1.8M in stock awards, accounting for 52% of the total pay in 2019.
Pinion also received $205.5K in non-equity incentive plan, $923.6K in option awards, $447.7K in salary and $37.5K in other compensation.
Rankings
In 2019, John R. Pinion II's compensation ranked 3,632nd out of 13,971 executives tracked by ExecPay. In other words, Pinion earned more than 74.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,632 out of 13,971 | 74th |
Division Manufacturing | 1,312 out of 5,695 | 77th |
Major group Chemicals And Allied Products | 456 out of 2,194 | 79th |
Industry group Drugs | 382 out of 1,880 | 80th |
Industry Pharmaceutical Preparations | 287 out of 1,392 | 79th |
Source: SEC filing on April 29, 2020.
Pinion's colleagues
We found four more compensation records of executives who worked with John R. Pinion II at Ultragenyx Pharmaceutical in 2019.
2019
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2019
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2019
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
2019
Thomas Kassberg
Ultragenyx Pharmaceutical